Arch Neurol 43:383384 Smith SA, Miller RG, Murphy JR et al (1994) Treatment of ALS with high dose pulse cyclophosphamide
doi: 10.1016/j.carbpol.2021.118898 131 KangSKimJParkYLeeHJeongJKimMet al
Combination approaches may prove optimal for many individuals
GLP-1 medicines usually slow stomach emptying
Ltd., Biosint S.p.A, Cayman Chemical, ChengDa PharmaCeuticals Co., Ltd., HuangGang HuaYang Pharmaceutical Co., Ltd., Kaiyuan Hengtai Nutrition Co., Ltd., Lonza Group Ltd., Maxsun Industries Incorporated, MERCK KGaA, Northeast Pharmaceutical Group Co., Ltd., while also analyzing key developments in novel ideas, disruptive products, and innovative services that could reshape the future market and reveal emerging themes across the industry